What types of Hepatitis C does Mavyret treat?

Mavyret (glecaprevir and pibrentasvir) is an oral treatment for all chronic hepatitis C virus (HCV) genotypes (1-6) in adult and pediatric patients 12 years and older.

Mavyret is FDA-approved for the treatment of adult and pediatric patients 12 years and older or weighing at least 45 kg with:

• chronic HCV genotype (GT) 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with compensated cirrhosis (Child-Pugh A).
• HCV genotype 1 infection, who previously have been treated with a regimen containing an HCV NS5A inhibitor or an NS3/4A protease inhibitor, but not both.